Gastroenterology - European Medical Journal

Continue

Gastroenterology

Articles
10 Mins
5th December 2019

A Rare Case of an Inflammatory Myofibroblastic Tumour of the Colon as a Probable Result of Tumour Recurrence after Hemicolectomy

Inflammatory myofibroblastic tumour (IMT) is a rare mesenchymal solid tumour commonly documented in children and young adults, but also found…
15 Mins
4th November 2019

Defining the Future of Inflammatory Bowel Disease Care: The Pivotal Role of Personalised Treatment

IBD is not one disease, but, rather, a whole range of diseases. It is a systemic immune disorder; therefore, in addition to causing conventional…
30 Mins
4th October 2019

Key Considerations in the Management of Inflammatory Bowel Disease: Interviews with Key Opinion Leaders

A paradigm shift has occurred in IBD management, whereby reducing inflammation and mucosal healing has become a the key endpoint that clinicians…
17 Mins
20th June 2019

IL-12/23 in IBD: Making the Best Use of Available Evidence

This satellite symposium took place on 7th March 2019, as part of the 14th Congress of the European Crohn’s and Colitis Organisation (ECCO) in Copenhagen…
16 Mins
13th June 2019

The IBD Pathway: From a Patient Perspective

A highly interactive symposium, including pre-recorded interviews with patients, was chaired by Prof Geert D’Haens. Participation by the audience was…
14 Mins
13th June 2019

The IBD Management Puzzle: Do We Have All the Pieces?

IBD shows a progressive immunopathogenesis.1 Following an initial immune response, amplification of this inflammatory response leads to the phenotypic…
15 Mins
11th December 2018

A Worldwide Perspective on Diagnosis and Management of Diverticular Disease: Understanding Similarities and Differences

The epidemiology of diverticular disease (DD) is changing, with an increasing prevalence in younger patients from Europe and the USA, and changing disease…
13 Mins
11th December 2018

The Emerging Treatment Landscape of Inflammatory Bowel Disease: Role of Innovator Biologics and Biosimilars

Despite the fact that the treatment armamentarium for inflammatory bowel diseases (IBD) is growing, unmet medical needs remain…